Rivaroxaban in cervical and "cervico-cerebral" artery dissections: a new therapeutic option?
Malferrari, Giovanni; Laterza, Domenico; Valzania, Franco; Monaco, Daniela; Silingardi, Mauro; Pizzini, Attilia Maria.
; 40(8): 1591-1596, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-30980197
Reversal strategies in patients treated with direct oral anticoagulants.
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
[PRACTICAL ADVICE FOR THE APPROPRIATE USE OF DIRECT ORAL ANTICOAGULANTS].
The pharmacology of novel oral anticoagulants.
Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer.
Reversal of Direct Oral Anticoagulants: Current Status and Future Directions.
Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis.
Emerging therapeutic uses of direct-acting oral anticoagulants: An evidence-based perspective.
Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis.
Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants.